The state of low oxygen levels known as hypoxia in humans is considered a dangerous condition is apparently a normal physiological condition and required by the stem cells as they are in the body.
treated again either conservatively or operatively (Kelly & Porucznik, 2014) . In the field of orthopedics, stem cell therapy can be used primarily for bone defect transplantation, in non-union cases, spinal cord injuries and peripheral nerve injuries, in the treatment of osteonecrosis, and, more recently, for tissue engineering purposes for patients with congenital anomalies.
The state of low oxygen levels known as hypoxia in humans is considered as a dangerous condition, is apparently a normal physiological condition and required by stem cells like when in the body (niche). Stem Cells (MSCs) require physiologically low optimal O2 tension of 1-3% in bone marrow (Chow et al., 2010) , 10-15% adipose tissue (Bizzari et al., 2006) and 2-9% in almost all body tissues (Gruber et al., 2010) , whereas in the seminiferous tubules testes required 0.2 to 1-6% gradation for spermatogenesis (Wenger and Katschinski, 2005) .
Although it can be taken from multiple sources, MSC concentrations in tissues are very low, and impossible to isolate the 50-2x108MSCs (the amount usually used in clinical trials) from the donor for each therapy.
Thus, in vitro conventional culture to proliferate MSC has become an inevitable choice. (Haque et al., 2013) . 
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